RESEARCH TRIANGLE PARK, N.C., Oct. 13, 2016 /PRNewswire/ -- bioMONTR Labs announced today they have entered into new MasterService Agreements to provide HIV-1 viral load testing services for CytoDyn's ongoing Phase 2b PRO 140 Monotherapy Extension Study and their upcoming Phase 3 PRO 140 Monotherapy Study.
Logo - http://photos.prnewswire.com/prnh/20161013/428641LOGO
Financial terms were not disclosed.
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biomontr-labs-to-provide-testing-services-for-cytodyn-pro-140-clinical-trials-300344770.html
SOURCE bioMONTR Labs
Subscribe to our Free Newsletters!
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...
Bile duct cancer occurs either within the liver or the point where the bile ducts emerge from the ...
Xeroderma pigmentosum is a rare inherited condition marked by extreme sensitivity to sunlight and ...View All